Status:
COMPLETED
Serum Free Light Change in Multiple Myeloma
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to evaluate the predictive role of free Kappa/Lambda ration in Multiple Myeloma post-transplant.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic stem cell transplantation.
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00910078
Last Update
May 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera S. Giovanni Battista
Torino, Torino, Italy, 10126